Supplementary Table S9 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression

Supplementary Table S9 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression

<p>Supplementary Table S9. Quantification of each protein-specific band normalized to vinculin (Dox-inducible C4-2b–derived models, Fig. 4D, upper panel).</p>

Gorde:
Xehetasun bibliografikoak
Egile nagusia: Chuandong Geng (17315310) (author)
Beste egile batzuk: Man-Chao Zhang (17315313) (author), Ganiraju C. Manyam (17315316) (author), Jody V. Vykoukal (17315319) (author), Johannes F. Fahrmann (15052230) (author), Shan Peng (17315322) (author), Cheng Wu (17315325) (author), Sanghee Park (17315328) (author), Shakuntala Kondraganti (17315331) (author), Daoqi Wang (17315334) (author), Brian D. Robinson (16755326) (author), Massimo Loda (14958363) (author), Christopher E. Barbieri (15012150) (author), Timothy A. Yap (15028749) (author), Paul G. Corn (17315337) (author), Samir Hanash (17314360) (author), Bradley M. Broom (15022580) (author), Patrick G. Pilié (15119957) (author), Timothy C. Thompson (17315340) (author)
Argitaratua: 2025
Gaiak:
Cancer
Molecular and Cellular Biology
Therapeutic Research and Development
Cell Signaling
DNA Damage and Repair
Drug Mechanisms
Genitourinary Cancers
Prostate cancer
Small Molecule Agents
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak